Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery

NCT00438087 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 313

Last updated 2012-07-10

No results posted yet for this study

Summary

Facial palsy after surgical removal of cranial base tumors adherent to the nerve can partly be explained by inflammation.

Conditions

  • Facial Palsy

Interventions

DRUG

methylprednisolone

methylprednisolone administrated intra and post operatively

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Alexis BOZORG GRAYELI, MD,PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-03-31
Completion
2011-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00438087 on ClinicalTrials.gov